Literature DB >> 29674643

Diagnostic thresholds for free light chains in multiple myeloma depend on the assay used.

Xavier Bossuyt1,2, Michel Delforge3, Martin Reynders4, Doreen Dillaerts5, Ben Sprangers6, Karel Fostier7, Koen Poesen4,8, Martine Vercammen9,10.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29674643     DOI： 10.1038/s41375-018-0041-0

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  3 in total

1.  Comparison of 2 Serum-Free Light-Chain Assays in CKD Patients.

Authors:  Ben Sprangers; Kathleen Claes; Pieter Evenepoel; Dirk Kuypers; Koen Poesen; Michel Delforge; Xavier Bossuyt V; Björn Meijers
Journal:  Kidney Int Rep       Date:  2020-01-30

2.  Comparison of three different serum-free light-chain assays-implications on diagnostic and therapeutic monitoring of multiple myeloma.

Authors:  Aneta Schieferdecker; Sebastian Hörber; Monika Ums; Britta Besemer; Carsten Bokemeyer; Andreas Peter; Katja Weisel
Journal:  Blood Cancer J       Date:  2020-01-09       Impact factor: 11.037

3.  Role of Serum Free Light Chain Assay in Relapsed/Refractory Multiple Myeloma. A Real-Life Unicentric Retrospective Study.

Authors:  Uros Markovic; Alessandra Romano; Claudia Bellofiore; Annalisa Condorelli; Bruno Garibaldi; Anna Bulla; Andrea Duminuco; Vittorio Del Fabro; Francesco Di Raimondo; Concetta Conticello
Journal:  Cancers (Basel)       Date:  2021-11-29       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.